Exercise Testing and Other Tools for Risk Stratification in~Asymptomatic Patients

  • Corey H. Evans
  • Victor F. Froelicher

There are several reasons to desire tools to help identify asymptomatic patients who are at increased risk for future cardiac events or premature mortality. If one could identify asymptomatic patients who are developing premature coronary disease then medical treatment could begin earlier. One would also wish to identify asymptomatic patients who are at such increased risk that surgical/intra-coronary artery interventions would increase survival and prevent cardiovascular (CV) events. Lastly, there are certain patients in high-risk occupations where a coronary event would threaten the lives of others. These patients should be identified.


Asymptomatic Patient Coronary Artery Calcium Traditional Risk Factor Framingham Risk Score Coronary Calcium Score 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    O’Rourke RA, Brundage BH, Froelicher VF, et al. American College of Cardiology/American Heart Association Expert Consensus document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. Circulation 2000; 102:126–40.PubMedGoogle Scholar
  2. 2.
    Taylor AJ, Bairey Merz CN, Udelson JE, et al. Can Atherosclerosis Imaging Techniques Improve the Detection of Patients at Risk for Ischemic Heart Disease? Presented at the 34th Bethesda Conference, Bethesda, Maryland, October 7, 2002, J Am Coll Cardiol 2003; 41:1855–917.Google Scholar
  3. 3.
    Grundy SM, Pasternak R, Greenland P, et al. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation 1999; 100:1481–92.PubMedGoogle Scholar
  4. 4.
    Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285:2486–97.Google Scholar
  5. 5.
    Burde and Virmani et al. Pathologic Basis for New Atherosclerosis Imaging Techniques, in 34th Bethesda Conference, ibid. p 1881.Google Scholar
  6. 6.
    Arad Y, Spadaro LA, Goodman K, et al. Predictive value of electron beam CT of the coronary arteries: 19 month follow-up of 1173 asymptomatic subjects. Circulation 1996; 93:1951–1953.PubMedGoogle Scholar
  7. 7.
    Redberg, RF and Vogel RA, What is the Spectrum of Current and Emerging Techniques for the Noninvasive Measurement of Atherosclerosis? 34th Bethesda Conference, ibid, page 1889.Google Scholar
  8. 8.
    Greenland P, LaBree L, Azen SP, et al. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA 2004; 291:210–215.PubMedCrossRefGoogle Scholar
  9. 9.
    Greenland P, Bonow RO, Brundage BH, et al. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force. J Am Coll Cardiol 2007; 49: 378–402.PubMedCrossRefGoogle Scholar
  10. 10.
    ACC/AHA Clinical Competence Statement of Cardiac Imaging with Computed Tomography and Magnetic Resonance. JACC 2005;46:383–402.Google Scholar
  11. 11.
    Greenland P, et al. Prevention Conference V: Beyond Secondary Prevention; Identifying the High-Risk Patient for Primary Prevention, Noninvasive Test of Atherosclerotic Burden. Circulation 2000; 101: e16–e22.PubMedGoogle Scholar
  12. 12.
    Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992; 326:381–6.PubMedGoogle Scholar
  13. 13.
    Chambless LE, Heiss G, Folsom AR et al. Carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study 1987–1993. Am J Epidemiol 1997; 146:483–494.PubMedGoogle Scholar
  14. 14.
    O’Leary DH, Polak JF, Kronmal RA, et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults: Cardiovascular Health Study. N Engl J Med 1999; 340:14–22.PubMedCrossRefGoogle Scholar
  15. 15.
    Honda O, Sugiyama S, Kugiyama K, et al. Echolucent carotid plaques predict future coronary events in patients with coronary artery disease. J Amer Coll Cardiol 2004; 43: 1177–84.CrossRefGoogle Scholar
  16. 16.
    Toussaint JF, LaMuraglia GM, Southern JF et al. Magnetic resonance images lipid, fibrous, calcified, hemorrhagic and thrombotic components of human atherosclerosis in vivo. Circulation 1996; 94: 932–8.PubMedGoogle Scholar
  17. 17.
    Froelicher VF and Myers J. Exercise and the Heart, 5th Ed. Saunders Elsevier, Philadelphia, 2006, 361–6.Google Scholar
  18. 18.
    Multiple Risk Factor Intervention Research Group: Exercise electrocardiogram and coronary heart disease mortality in the multiple risk factor intervention trial. Am J Cardiol 1985;55: 16–24.Google Scholar
  19. 19.
    Gibbons LW, Mitchell TL, Wei M, et al. Maximal exercise test as a predictor of risk for mortality from coronary heart disease in asymptomatic men. Am J Cardiol 2000; 86: 53–58.PubMedCrossRefGoogle Scholar
  20. 20.
    Balady GJ, Larson MG, Vasan RS, et al. Usefulness of exercise testing in the prediction of coronary disease risk among asymptomatic persons as a function of the Framingham risk score. Circulation 2004; 10:1920–25.CrossRefGoogle Scholar
  21. 21.
    Bodegard J, Erikssen G, Bjornhold JV, et al. Reasons for terminating an exercise test provide independent prognostic information. 2014 apparently healthy men followed for 26 years. Eur Hear J doi: 10.1093/eurheartj/ehi278.Google Scholar
  22. 22.
    Froelicher VF and Myers J. Exercise and the Heart, 5th Ed. Saunders Elsevier, Philadelphia, 2006, 367–8.Google Scholar
  23. 23.
    Myers J, Kaykha A, George S, et al. Fitness versus physical activity patterns in predicting mortality in men. Am J Med 2004; 117:912–918.PubMedCrossRefGoogle Scholar
  24. 24.
    Froelicher VF. Screening with the exercise test: time for a guideline change? Eur Heart J. doi:10.1093/eurheartj/ehi303.Google Scholar
  25. 25.
    Froelicher VF and Myers J. Exercise and the Heart, 5th Ed. Saunders Elsevier, Philadelphia, 2006, preface, ix.Google Scholar
  26. 26.
    Pearson TA, Mensah GA, et al. Markers of Inflammation and Cardiovascular Disease, Application to Clinical and Public Health practice, A statement for Healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107:499–511.PubMedCrossRefGoogle Scholar
  27. 27.
    Wang TF, Gona P Larson MG, et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Eng J Med 2006; 355:2631–9.CrossRefGoogle Scholar
  28. 28.
    Ware JH, The limitations of risk factors as prognostic tools. N Eng J Med 2006; 355: 2615–7.CrossRefGoogle Scholar
  29. 29.
    Sigal, RJ, Kenny GP, Wasserman, DH, et al. Physical Activity/Exercise and Type 2 Diabetes; A Consensus Statement from the American Diabetes Association. Diabetes Care 2006; 29: 1433–1438.PubMedCrossRefGoogle Scholar
  30. 30.
    Greenland P and Graziano JM. Selecting Asymptomatic Patients for coronary computed tomography or electrocardiographic exercise testing. N Engl J Med 2003; 349: 465–73.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Corey H. Evans
    • 1
    • 2
  • Victor F. Froelicher
    • 3
  1. 1.St. Anthony’s Hospital
  2. 2.Florida Institute of Family MedicineUSA
  3. 3.Department of CardiologyStanford/Palo Alto Veterans Affairs Health Care CenterPalo AltoUSA

Personalised recommendations